1. Home
  2. ERO vs MIRM Comparison

ERO vs MIRM Comparison

Compare ERO & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ERO
  • MIRM
  • Stock Information
  • Founded
  • ERO 2016
  • MIRM 2018
  • Country
  • ERO Canada
  • MIRM United States
  • Employees
  • ERO N/A
  • MIRM N/A
  • Industry
  • ERO
  • MIRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • ERO
  • MIRM Health Care
  • Exchange
  • ERO Nasdaq
  • MIRM Nasdaq
  • Market Cap
  • ERO 1.9B
  • MIRM 1.9B
  • IPO Year
  • ERO N/A
  • MIRM 2019
  • Fundamental
  • Price
  • ERO $15.28
  • MIRM $44.50
  • Analyst Decision
  • ERO
  • MIRM Strong Buy
  • Analyst Count
  • ERO 0
  • MIRM 13
  • Target Price
  • ERO N/A
  • MIRM $57.00
  • AVG Volume (30 Days)
  • ERO 401.3K
  • MIRM 356.8K
  • Earning Date
  • ERO 11-05-2024
  • MIRM 11-12-2024
  • Dividend Yield
  • ERO N/A
  • MIRM N/A
  • EPS Growth
  • ERO N/A
  • MIRM N/A
  • EPS
  • ERO 0.17
  • MIRM N/A
  • Revenue
  • ERO $464,134,000.00
  • MIRM $307,028,000.00
  • Revenue This Year
  • ERO $45.00
  • MIRM $73.07
  • Revenue Next Year
  • ERO $71.17
  • MIRM $27.98
  • P/E Ratio
  • ERO $92.97
  • MIRM N/A
  • Revenue Growth
  • ERO 8.51
  • MIRM 112.14
  • 52 Week Low
  • ERO $11.56
  • MIRM $23.14
  • 52 Week High
  • ERO $24.34
  • MIRM $48.89
  • Technical
  • Relative Strength Index (RSI)
  • ERO 27.16
  • MIRM 65.32
  • Support Level
  • ERO $16.40
  • MIRM $41.09
  • Resistance Level
  • ERO $16.60
  • MIRM $48.89
  • Average True Range (ATR)
  • ERO 0.66
  • MIRM 2.16
  • MACD
  • ERO -0.28
  • MIRM 0.57
  • Stochastic Oscillator
  • ERO 1.89
  • MIRM 59.09

About ERO Ero Copper Corp.

Ero Copper Corp is a base metals mining company. It is predominantly focused on the production and sale of copper with gold and silver produced and sold as by-products. Ero's operations are segmented between its mines in Brazil, the Caraiba Operations and the Xavantina Operations, its development project, the Tucuma Project in Brazil and corporate. Majority revenue is generated from its Caraiba Operations segment which consists of mining operations and processing facilities including the Pilar and Vermelhos underground mines and the Surubim open pit mine.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter "IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: